SEC 13F Intelligence

Venrock Adviser, LLC / CATBUSD

Venrock Adviser, LLC’s Astria Therapeutics Inc Position

Does Venrock Adviser, LLC own Astria Therapeutics Inc (CATBUSD)? Not currently — the last reported position was 2.46M shares worth $18M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$18M
Q3 2025
Shares
2.46M
% of Portfolio
+1.01%
Quarters Held
11
position exited

Position History CATBUSD

Reported value by quarter
Q3 ’21: $5MQ3 ’21Q4 ’21: $3MQ1 ’22: $4MQ1 ’22Q4 ’23: $25MQ1 ’24: $51MQ1 ’24Q2 ’24: $33MQ3 ’24: $38MQ3 ’24Q4 ’24: $22MQ1 ’25: $13MQ1 ’25Q2 ’25: $13MQ3 ’25: $18MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20252.46M$18M+1.01%
Q2 20252.46M$13M+0.99%
Q1 20252.46M$13M+1.12%
Q4 20242.46M$22M+1.51%
Q3 20243.46M$38M+1.99%
Q2 20243.61M$33M+2.09%
Q1 20243.61M$51M+2.42%
Q4 20233.23M$25M+1.70%
Q1 2022539.0K$4M+0.59%
Q4 2021539.0K$3M+0.40%
Q3 2021539.0K$5M+0.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venrock Adviser, LLC’s full portfolio or all institutional holders of CATBUSD.